Leg 500 Week 9 Assignment 4 – Strayer

Front 1

Visit www.hwgala.com

Back 1

LEG 500 Week 9 Assignment 4 – Strayer Click On The LinkBelow to Purchase A+ Graded MaterialInstant Download http://www.hwgala.com/LEG-500-Week-9-Assignment-4-Strayer-NEW-LEG500A4.htm Assignment 4: Legal and Ethical Considerations in Marketing,Product Safety, and Intellectual PropertyDue Week 9 andworth 300 pointsYou are a newassociate at the law firm of Dewey, Chetum, and Howe. John, a former researcherat PharmaCARE, comes to your office. He has concerns about PharmaCARE’s use ofAD23, one of the company’s top-selling diabetes drugs. Two (2) years ago, afterPharmaCARE’s research indicated that AD23 might also slow the progression ofAlzheimer’s disease, John and his team of pharmacists began reformulating thedrug to maximize that effect. In order to avoid the Food and DrugAdministration’s (FDA) scrutiny, PharmaCARE established a wholly-owned subsidiary,CompCARE, to operate as a compounding pharmacy to sell the new formulation toindividuals on a prescription basis. CompCARE established itself in a suburbanoffice park near its parent’s headquarters. To conserve money and time,CompCARE did a quick, low-cost renovation.CompCARE benefitedfrom PharmaCARE’s reputation, databases, networks, and sales and marketingexpertise, and within six (6) months had the medical community buzzing aboutAD23. Demand soared, particularly among Medicare, Medicaid, and VeteransAffairs patients. Seeing the opportunity to realize even more profit, CompCAREbegan advertising AD23 directly to consumers and marketing the drug directly tohospitals, clinics, and physician offices, even though compounding pharmaciesare not permitted to sell drugs in bulk for general use. To circumvent thistechnicality, CompCARE encouraged doctors to fax lists of fictitious patientnames to CompCAREnabledξ���π

Front 2

Visit www.hwgala.com

Back 2

LEG 500 Week 9 Assignment 4 – Strayer Click On The LinkBelow to Purchase A+ Graded MaterialInstant Download http://www.hwgala.com/LEG-500-Week-9-Assignment-4-Strayer-NEW-LEG500A4.htm Assignment 4: Legal and Ethical Considerations in Marketing,Product Safety, and Intellectual PropertyDue Week 9 andworth 300 pointsYou are a newassociate at the law firm of Dewey, Chetum, and Howe. John, a former researcherat PharmaCARE, comes to your office. He has concerns about PharmaCARE’s use ofAD23, one of the company’s top-selling diabetes drugs. Two (2) years ago, afterPharmaCARE’s research indicated that AD23 might also slow the progression ofAlzheimer’s disease, John and his team of pharmacists began reformulating thedrug to maximize that effect. In order to avoid the Food and DrugAdministration’s (FDA) scrutiny, PharmaCARE established a wholly-owned subsidiary,CompCARE, to operate as a compounding pharmacy to sell the new formulation toindividuals on a prescription basis. CompCARE established itself in a suburbanoffice park near its parent’s headquarters. To conserve money and time,CompCARE did a quick, low-cost renovation.CompCARE benefitedfrom PharmaCARE’s reputation, databases, networks, and sales and marketingexpertise, and within six (6) months had the medical community buzzing aboutAD23. Demand soared, particularly among Medicare, Medicaid, and VeteransAffairs patients. Seeing the opportunity to realize even more profit, CompCAREbegan advertising AD23 directly to consumers and marketing the drug directly tohospitals, clinics, and physician offices, even though compounding pharmaciesare not permitted to sell drugs in bulk for general use. To circumvent thistechnicality, CompCARE encouraged doctors to fax lists of fictitious patientnames to CompCAREnabledξ���π

Front 3

Visit www.hwgala.com

Back 3

LEG 500 Week 9 Assignment 4 – Strayer Click On The LinkBelow to Purchase A+ Graded MaterialInstant Download http://www.hwgala.com/LEG-500-Week-9-Assignment-4-Strayer-NEW-LEG500A4.htm Assignment 4: Legal and Ethical Considerations in Marketing,Product Safety, and Intellectual PropertyDue Week 9 andworth 300 pointsYou are a newassociate at the law firm of Dewey, Chetum, and Howe. John, a former researcherat PharmaCARE, comes to your office. He has concerns about PharmaCARE’s use ofAD23, one of the company’s top-selling diabetes drugs. Two (2) years ago, afterPharmaCARE’s research indicated that AD23 might also slow the progression ofAlzheimer’s disease, John and his team of pharmacists began reformulating thedrug to maximize that effect. In order to avoid the Food and DrugAdministration’s (FDA) scrutiny, PharmaCARE established a wholly-owned subsidiary,CompCARE, to operate as a compounding pharmacy to sell the new formulation toindividuals on a prescription basis. CompCARE established itself in a suburbanoffice park near its parent’s headquarters. To conserve money and time,CompCARE did a quick, low-cost renovation.CompCARE benefitedfrom PharmaCARE’s reputation, databases, networks, and sales and marketingexpertise, and within six (6) months had the medical community buzzing aboutAD23. Demand soared, particularly among Medicare, Medicaid, and VeteransAffairs patients. Seeing the opportunity to realize even more profit, CompCAREbegan advertising AD23 directly to consumers and marketing the drug directly tohospitals, clinics, and physician offices, even though compounding pharmaciesare not permitted to sell drugs in bulk for general use. To circumvent thistechnicality, CompCARE encouraged doctors to fax lists of fictitious patientnames to CompCAREnabledξ���π